Trial C-144-01 (TIL)

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial

Trial acronym

C-144-01 (TIL)

Full title

A Phase 2, Multicenter Study to Assess the Efficacy and Safety of Autologous Tumor Infiltrating Lymphocytes (LN-144) for Treatment of Patients with Metastatic Melanoma Z-Nummer: 362 - CAVE: Screening nur nach OK von Sponsor!

NCT number

NCT02360579

Responsible organization

3. Med 3. Med Ismaninger Str. 22 81675 München Germany

Indications

Classification	Code	Description
-		Skincancers

Trial design

Phase

Status

Recruitment finished

Votes

Initiiation & lock

Date of lock (planned / actual)

Unknown / Unknown

Therapy

Sonstige - Therapieart: palliativ

Participants

	Function	Prename	Surname	Organization
	Responsible contact	Judith	Hecker	3. Med 3. Med Ismaninger Str. 22 81675 München Germany